Comparison of the Effectiveness of Virtual Reality Exposure Therapy with Eye Movement Desensitization and Reprocessing Therapy on Symptoms of Acrophobia and Anxiety Sensitivity

Comparison of the Effectiveness of Virtual Reality Exposure Therapy with Eye Movement Desensitization and Reprocessing Therapy on Symptoms of Acrophobia and Anxiety Sensitivity in Adolescent Girls

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210213050343N1

Enrollment

Registered

2021-07-12

Start date

2021-06-20

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fear of Heights or Acrophobia. Acrophobia

Interventions

Intervention 1: Intervention group: VRET is conducte by using a Desktop Computer with specifications

Graphics Card: ASUS NVIDIA GEFORCE GTX 1060 6GB GDDR5, CPU: Core i7-4790 (8M Cache, up to 4.00 GHz), RAM: 8 GB DDR4, and an Oculus Rift Dk2 Virtual Reality Headset. These tools make it possible to cre

Eligibility

Sex/Gender

Female

Age

14 Years to 18 Years

Inclusion criteria

Inclusion criteria: A score greater than or equal to 50 in the Acrophobia Questionnaire fulfillment of all specific phobia diagnostic criteria (eg, acrophobia) based on SCID-5 submission of written consent for participation in the study by participants and their parents Age 14 to 18 years

Exclusion criteria

Exclusion criteria: patients with hearing or visual impairment such as stereoscopy blindness or nystagmus presence of any other mental disorders as assessed using the structured clinical interview presence of specific physiological illnesses such as heart, lung and respiratory diseases, epilepsy and seizures developmental or intellectual disability, cognitive impairment, known balance disorders such as vertigo, dependent on alcohol or drugs other current psychological treatment

Design outcomes

Primary

Measure	Time frame
Acrophobia: Severe anxiety when standing in high places or watching other people in such situations causes severe fear in people with a phobia. As in other fears, one is fully aware of the irrationality and irrationality of one's fears but nevertheless cannot overcome them. These people try to avoid facing such situations, so that avoidance may have a negative impact on their personal or social life.Anxiety Sensitivity: It is a structure of individual differences in which the individual is afraid of the physical symptoms associated with anxiety arousal (increased heart rate, shortness of breath, dizziness) and basically arises from the belief that these symptoms have potentially harmful consequences. Social, cognitive, and physical leads. Timepoint: One week before the intervention and one week after the last intervention session. Method of measurement: Acrophobia Questionnaire and Anxiety Sensitivity Questionnaire.	—

Measure

Time frame

Acrophobia: Severe anxiety when standing in high places or watching other people in such situations causes severe fear in people with a phobia. As in other fears, one is fully aware of the irrationality and irrationality of one's fears but nevertheless cannot overcome them. These people try to avoid facing such situations, so that avoidance may have a negative impact on their personal or social life.Anxiety Sensitivity: It is a structure of individual differences in which the individual is afraid of the physical symptoms associated with anxiety arousal (increased heart rate, shortness of breath, dizziness) and basically arises from the belief that these symptoms have potentially harmful consequences. Social, cognitive, and physical leads. Timepoint: One week before the intervention and one week after the last intervention session. Method of measurement: Acrophobia Questionnaire and Anxiety Sensitivity Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Azimisefat

Persian Gulf University

parisa0730@gmail.com+98 77 3122 2710

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026